A study evaluating general cutaneous side effects of anti‐PD‐1 therapy reported 11 patients with BP; primary tumors were either melanoma (5), non‐small cell lung carcinoma (2), urothelial carcinoma (2), or head and neck squamous cell carcinoma (1).10 This evidence concerns the gene PDCD1 and head and neck squamous cell carcinoma.